Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programme
Diabet. Med. 28, 724–730 (2011) Aims Several chronic care models for diabetes have been implemented in Italy, although conclusive data on their effectiveness are lacking. In the Cusano‐Milanino diabetes clinic, patients with Type 2 diabetes with a stable disease/therapy (i.e. a steady level of HbA1...
Saved in:
Published in: | Diabetic medicine Vol. 28; no. 6; pp. 724 - 730 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford, UK
Blackwell Publishing Ltd
01-06-2011
Blackwell |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Diabet. Med. 28, 724–730 (2011)
Aims Several chronic care models for diabetes have been implemented in Italy, although conclusive data on their effectiveness are lacking. In the Cusano‐Milanino diabetes clinic, patients with Type 2 diabetes with a stable disease/therapy (i.e. a steady level of HbA1c without need for therapy changes) are included in the SINERGIA programme: diabetologists, nurses and dietitians empower patients and telemedicine resources are utilized efficiently.
Methods Clinical outcomes measured in the year before and after the initiation of SINERGIA were compared. A generalized hierarchical linear regression model for repeated measures was used.
Results Altogether, 1004 patients were included; baseline characteristics were (mean ± sd): age 66.6 ± 6.2 years, 54.1% male, diabetes duration 10.8 ± 7.7 years, BMI 29.5 ± 4.8 kg/m2, HbA1c 6.9 ± 0.9% (52 ± 14 mmol/mol); 72.9% of patients were treated with anti‐hypertensive drugs; 32.7% were treated with lipid‐lowering drugs. After a median follow‐up of 12 months (range 6–24 months), the proportion of patients with HbA1c≤ 7.0% (≤ 53 mmol/mol) increased from 32.7 to 45.8% (P < 0.0001), while those with HbA1c≥ 9% (≥ 75 mmol/mol) decreased from 10.5 to 4.3% (P < 0.0001). Patients with LDL cholesterol < 100 mg/dl (< 2.59 mmol/l) increased from 40 to 47% (P < 0.0001), while those with LDL cholesterol ≥ 130 mg/dl (≥ 3.36 mmol/l) decreased from 26.6 to 19.7%; blood pressure levels were slightly improved. The mean number of face‐to‐face encounters decreased from (median and range) 2.8 (2.3–3.4) to 2.3 (1.9–2.7) (P < 0.0001) visits per patient/year.
Conclusions The SINERGIA model is effective in improving metabolic control and major cardiovascular risk factors, while allowing diabetologists to dedicate more time to patients with more acute disease. |
---|---|
Bibliography: | ark:/67375/WNG-CRL2FTCX-M ArticleID:DME3253 istex:E3B1D5F55BDDCE0618097E83D7A9D02E10A60870 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0742-3071 1464-5491 |
DOI: | 10.1111/j.1464-5491.2011.03253.x |